The Travails of Neuroprotective Drug Development forAcute Ischemic Stroke | Citedby Results | European Neurology | Karger Publishers

Skip to Main Content

Skip Nav Destination

The Travails of Neuroprotective Drug Development forAcute Ischemic Stroke

Eur Neurol (1998) 40 (2): 65–66.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Clinical syndromes of neurotransmitter system dysfunction in severe brain injury

E. V. Aleksandrova
O. S. Zaytsev
A. A. Potapov

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (2015) 115 (7): 40.

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

Amos Adeleye
Esther Shohami
Dean Nachman
Alexander Alexandrovich
Victoria Trembovler
Rami Yaka
Yigal Shoshan
Jasbeer Dhawan
Anat Biegon

European Journal of Pharmacology (2010) 629 (1-3): 25.

Dynamic changes in N -methyl- d -aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits

Anat Biegon
Pamela A. Fry
Charles M. Paden
Alexander Alexandrovich
Jeanna Tsenter
Esther Shohami

Proceedings of the National Academy of Sciences (2004) 101 (14): 5117.

Neuroprotection in ischemic stroke—combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia

Karsten Schöller
Stefan Zausinger
Alexander Baethmann
Robert Schmid-Elsaesser

Brain Research (2004) 1023 (2): 272.

Understanding and managing ischemic stroke

Philip A Barber
Roland N Auer
Alastair M Buchan
Garnette R Sutherland

Canadian Journal of Physiology and Pharmacology (2001) 79 (3): 283.